Table of Content


1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Molecular Imaging
4.2.2 Increasing Demand for Non-invasive Small Animal Imaging Techniques
4.2.3 Increase in Preclinical Research Funding, by Both Private and Public Organizations
4.3 Market Restraints
4.3.1 Strict Regulations in Preclinical Research
4.3.2 High Installation and Operational Costs associated with Preclinical Imaging Modalities
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Modality
5.1.1 Optical Imaging Systems
5.1.2 Nuclear Imaging Systems
5.1.3 Micro-MRI
5.1.4 Micro-ultrasound
5.1.5 Micro-CT
5.1.6 Photoacoustic Imaging Systems
5.1.7 Other Modality
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia - Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aspect Imaging Ltd
6.1.2 Bruker Corporation
6.1.3 Fujifilm Holdings Corporation
6.1.4 Li-Cor Biosciences
6.1.5 Mediso Ltd
6.1.6 Milabs BV
6.1.7 MR Solutions Ltd
6.1.8 PerkinElmer Inc.
6.1.9 Trifoil Imaging


7 MARKET OPPORTUNITIES AND FUTURE TRENDS